This observation is consistent with previous studies showing that missense mutations in Trp53 promote malignant transformation by abrogating both the tumor suppressive and promoting the oncogenic (gain-of-function and/or dominant negative) functions of Trp53 in vivo [23, 56–59]. The gene discussed is TP53; the disease is neoplasm.